Cidara Therapeutics Announces Pricing of Initial Public Offering
15 avr. 2015 07h30 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, April 15, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
VaxInnate Receives Extension of Contract from BARDA for Development of Seasonal and Pandemic Influenza Vaccines
17 févr. 2015 08h00 HE
|
VaxInnate Corporation
Cranbury, NJ, Feb. 17, 2015 (GLOBE NEWSWIRE) -- VaxInnate Corporation, a biotechnology firm pioneering a
breakthrough vaccine technology, today announced that it has
executed a contract modification...
VaxInnate Initiates Phase 1b/2 Clinical Trial of Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, in Elderly
08 déc. 2014 08h00 HE
|
VaxInnate Corporation
Cranbury, NJ, Dec. 8, 2014 (GLOBE NEWSWIRE) -- VaxInnate Corporation, a biotechnology firm pioneering a
breakthrough vaccine technology platform, today announced the
initiation of a double-blind,...
Point-of-Care Technologies Will Transform Customer Markets in the Next Decade
06 mars 2014 07h30 HE
|
Lux Research
BOSTON, MA--(Marketwired - Mar 6, 2014) - Fueled by point-of-care (POC) technologies, the health care industry is headed for transformative change toward a patient-centric model. The near-term...
Fedora Pharmaceuticals Demonstrates that FPI-1465 Increases Activity of Certain Antibiotics against Drug-Resistant Bacteria
12 sept. 2013 13h00 HE
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Sept. 12, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. and its collaborators presented
results of preclinical studies demonstrating that FPI-1465 increases
the activity of...
Tune in to Genesis Global Radio This Week to Hear Guests Paula Webster-Grant, Rhonda Knutson, Patricia Fayerweather-Harlow, Kimberly Berg, Joanne Charette, Dr. Carlos Guerra, M.J. Domet, and Dr. Barbara Morrison
08 avr. 2013 16h10 HE
|
Genesis Global Media, Inc.
NEW YORK, NY, April 8, 2013 (GLOBE NEWSWIRE) -- This Week, tune in to hear our guests share their expertise on
music production, life coaching, self-empowerment, advances in
infectious disease, the...
Battelle Wins $102M NIAID Biodefense Research Contract
18 juil. 2012 10h30 HE
|
Battelle
COLUMBUS, OH--(Marketwire - Jul 18, 2012) - Battelle has won a single-source award from the U.S. Department of Health and Human Services' National Institutes of Health for evaluation and testing...
Stellar Biotechnologies Announces Biotech Showcase 2012 Presentations
04 janv. 2012 09h10 HE
|
Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Jan 4, 2012) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) is pleased to announce that it will be making two presentations at...
ContraFect CEO Robert Nowinski Announces Agreement With The Rockefeller University to Commercialize Eight Patents Covering Bacterial Treatments
18 nov. 2010 09h12 HE
|
ContraFect Corporation
NEW YORK, NY--(Marketwire - November 18, 2010) - ContraFect Corporation, the company that is pioneering the use of recombinant proteins for the treatment of drug resistant bacteria, announced that it...
MIT Enterprise Forum of Cambridge Presents "Vaccines and Global Health: New Technologies Create Global Opportunities"
04 nov. 2009 15h40 HE
|
MIT Enterprise Forum of Cambridge
CAMBRIDGE, MA--(Marketwire - November 4, 2009) - On November 9, the MIT Enterprise Forum of
Cambridge will present a session on the development of new technologies
for the research, development and...